Wednesday 18 September 2024
15:00 BST / 16:00 CET / 10:00 EST
ICON is taking part in a Bioanalysis Zone panel discussion to discuss key developments within the field of immunogenicity.
During this session several industry experts will explore the techniques and platforms currently in use, and the challenges experienced in the field. We will examine the tiered approach to immunogenicity assessment and the aspects of regulatory guidance that are most difficult to understand. The role of AI and digital tools within immunogenicity testing will also be discussed.
This conversation will be guided by recent survey data collected by Bioanalysis Zone as part of their Immunogenicity Spotlight. The panel will supplement these findings with their own opinions and answer questions via a live Q&A session.
Discussion points will include:
- The platforms and techniques used to assess immunogenicity and how the choice of platform may change over time
- The factors to consider when developing immunogenicity assays
- The challenges associated with immunogenicity testing, including the setting of cut points
- How to overcome regulatory guidance hurdles
Panelists
Robert Kernstock, PhD, MBA
Stephen Bradley
Jenny Valentine
Timothy Hickling
Kyra Cowan